Luay Alalawi1, Matthew J Budoff2. 1. Department of Cardiology, Lundquist Institute at Harbor UCLA Medical Center, 1209 W 220th St, Torrance, CA, 90502, USA. 2. Department of Cardiology, Lundquist Institute at Harbor UCLA Medical Center, 1209 W 220th St, Torrance, CA, 90502, USA. mbudoff@lundquist.org.
Abstract
PURPOSE OF REVIEW: The emerging technologies in multidetector computed tomography scanners gave the ability to image coronary arteries in a single heartbeat, at a higher quality, and low radiation dose. Furthermore, incorporating artificial intelligence and machine learning into image processing and interpretation have extended the use for coronary computed tomography angiogram (CCTA) and its applications. In this review, we will explore the recent evidence and advances supporting CCTA to become the ultimate tool for coronary artery disease. RECENT FINDINGS: Results from the EVINCI, ISCHEMIA, SCOT-HEART, and PROMISE showed that CCTA is better in patients' risk stratification and in detecting subclinical atherosclerosis, resulting in earlier interventions and lesser events. Additionally, CCTA gave us a closer look on atherosclerotic disease by identifying different type of plaque and their clinical significance. Furthermore, FFRCT is a notable example of incorporating artificial intelligence into CCTA. This technology helped us to accurately and non-invasively identify flow limiting lesions, guiding revascularization. As a result of the recent evidence, CCTA have made its way into the chest pain guidelines all over the world. Moreover, CCTA have the potential to revolutionize our understanding and standards in screening, preventing, and managing heart disease.
PURPOSE OF REVIEW: The emerging technologies in multidetector computed tomography scanners gave the ability to image coronary arteries in a single heartbeat, at a higher quality, and low radiation dose. Furthermore, incorporating artificial intelligence and machine learning into image processing and interpretation have extended the use for coronary computed tomography angiogram (CCTA) and its applications. In this review, we will explore the recent evidence and advances supporting CCTA to become the ultimate tool for coronary artery disease. RECENT FINDINGS: Results from the EVINCI, ISCHEMIA, SCOT-HEART, and PROMISE showed that CCTA is better in patients' risk stratification and in detecting subclinical atherosclerosis, resulting in earlier interventions and lesser events. Additionally, CCTA gave us a closer look on atherosclerotic disease by identifying different type of plaque and their clinical significance. Furthermore, FFRCT is a notable example of incorporating artificial intelligence into CCTA. This technology helped us to accurately and non-invasively identify flow limiting lesions, guiding revascularization. As a result of the recent evidence, CCTA have made its way into the chest pain guidelines all over the world. Moreover, CCTA have the potential to revolutionize our understanding and standards in screening, preventing, and managing heart disease.
Authors: Thomas J Stocker; Simon Deseive; Jonathon Leipsic; Martin Hadamitzky; Marcus Y Chen; Ronen Rubinshtein; Mathias Heckner; Jeroen J Bax; Xiang-Ming Fang; Erik Lerkevang Grove; John Lesser; Pál Maurovich-Horvat; James Otton; Sanghoon Shin; Gianluca Pontone; Hugo Marques; Benjamin Chow; Cesar H Nomura; Ramzi Tabbalat; Axel Schmermund; Joon-Won Kang; Christopher Naoum; Melany Atkins; Eugenio Martuscelli; Steffen Massberg; Jörg Hausleiter Journal: Eur Heart J Date: 2018-11-01 Impact factor: 29.983
Authors: Matthew J Budoff; Dong Li; Ella A Kazerooni; Gregory S Thomas; Jennifer H Mieres; Leslee J Shaw Journal: Acad Radiol Date: 2016-10-19 Impact factor: 3.173
Authors: Danilo Neglia; Daniele Rovai; Chiara Caselli; Mikko Pietila; Anna Teresinska; Santiago Aguadé-Bruix; Maria Nazarena Pizzi; Giancarlo Todiere; Alessia Gimelli; Stephen Schroeder; Tanja Drosch; Rosa Poddighe; Giancarlo Casolo; Constantinos Anagnostopoulos; Francesca Pugliese; Francois Rouzet; Dominique Le Guludec; Francesco Cappelli; Serafina Valente; Gian Franco Gensini; Camilla Zawaideh; Selene Capitanio; Gianmario Sambuceti; Fabio Marsico; Pasquale Perrone Filardi; Covadonga Fernández-Golfín; Luis M Rincón; Frank P Graner; Michiel A de Graaf; Michael Fiechter; Julia Stehli; Oliver Gaemperli; Eliana Reyes; Sandy Nkomo; Maija Mäki; Valentina Lorenzoni; Giuseppe Turchetti; Clara Carpeggiani; Martina Marinelli; Stefano Puzzuoli; Maurizio Mangione; Paolo Marcheschi; Fabio Mariani; Daniela Giannessi; Stephan Nekolla; Massimo Lombardi; Rosa Sicari; Arthur J H A Scholte; José L Zamorano; Philipp A Kaufmann; S Richard Underwood; Juhani Knuuti Journal: Circ Cardiovasc Imaging Date: 2015-03 Impact factor: 7.792
Authors: Tom Finck; Julius Hardenberg; Albrecht Will; Eva Hendrich; Bernhard Haller; Stefan Martinoff; Jörg Hausleiter; Martin Hadamitzky Journal: JACC Cardiovasc Imaging Date: 2018-10-17
Authors: Matthew J Budoff; David Dowe; James G Jollis; Michael Gitter; John Sutherland; Edward Halamert; Markus Scherer; Raye Bellinger; Arthur Martin; Robert Benton; Augustin Delago; James K Min Journal: J Am Coll Cardiol Date: 2008-11-18 Impact factor: 24.094
Authors: G B John Mancini; Jonathan Leipsic; Matthew J Budoff; Cameron J Hague; James K Min; Susanna R Stevens; Harmony R Reynolds; Sean M O'Brien; Leslee J Shaw; Cholenahally N Manjunath; Kreton Mavromatis; Marcin Demkow; Jose Luis Lopez-Sendon; Alexander M Chernavskiy; Gilbert Gosselin; Herwig Schuchlenz; Gerard P Devlin; Anoop Chauhan; Sripal Bangalore; Judith S Hochman; David J Maron Journal: JACC Cardiovasc Imaging Date: 2021-01-13